• D H Kim, E-Y Moon, J H Yi, H E Lee, S J Park, Y-K Ryu, H-C Kim, S Lee, and J H Ryu.
• Department of Medicinal Biotechnology, College of Natural Resources and Life Science, Dong-A University, Busan 604-714, Republic of Korea; Dong-A Anti-Aging Research Center, Dong-A University, Busan 604-714, Republic of Korea.
• Neuroscience. 2015 Dec 3; 310: 51-62.

AbstractAlthough several studies have suggested the neuroprotective effect of thymosin β4 (TB4), a major actin-sequestering protein, on the central nervous system, little is understood regarding the action of N-acetyl-serylaspartyl-lysyl-proline (Ac-SDKP), a peptide fragment of TB4 on brain function. Here, we examined neurogenesis-stimulative effect of Ac-SDKP. Intrahippocampal infusion of Ac-SDKP facilitated the generation of new neurons in the hippocampus. Ac-SDKP-treated mouse hippocampus showed an increase in β-catenin stability with reduction of glycogen synthase kinase-3β (GSK-3β) activity. Moreover, inhibition of vascular endothelial growth factor (VEGF) signaling blocked Ac-SDKP-facilitated neural proliferation. Subchronic intrahippocampal infusion of Ac-SDKP also increased spatial memory. Taken together, these data demonstrate that Ac-SDKP functions as a regulator of neural proliferation and indicate that Ac-SDKP may be a therapeutic candidate for diseases characterized by neuronal loss.Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

38 keywords...

hide…